Safety and tolerability of once-daily tiotropium Respimat® add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma
Keyword(s):
2015 ◽
Vol 135
(2)
◽
pp. AB6
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 137
(2)
◽
pp. AB212
◽
2016 ◽
Vol 137
(2)
◽
pp. AB213
◽
Keyword(s):